Radiotherapy and razoxane in the palliative treatment of gastric cancer

Radiation Oncology Investigations

Volumn 4, Issue 1, 1996, Pages 27-32

  Rhomberg, W ^a   Bohler F ^a   Eiter, H ^a   Alton, R ^a   Maier, R ^a  

^a Landesklinikum ^*  (Austria)

Author keywords

gastric cancer; radiosensitizer; radiotherapy; razoxane

Indexed keywords

DOXORUBICIN; FLUOROURACIL; MITOMYCIN; RAZOXANE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PALLIATIVE THERAPY; PRIORITY JOURNAL; RADIOSENSITIZATION; STOMACH CANCER;

EID: 0029927133     PISSN: 10657541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6823(1996)4:1<27::AID-ROI5>3.0.CO;2-O     Document Type: Article

References (35)

1. DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer Principles and Practice of Oncology. 4th Ed. Philadelphia: J.B. Lippincott Co., p 844, 1993.
2. Friedman MA, Ogawa M, Carter SK, Sakrai Y, Kimura J, Hannigan J: Chemotherapy of disseminated gastric cancer. A joint effort of the Northern California Oncology Group and the Japanese Gastric Cancer Chemotherapy Group. Cancer 52:1771-1777, 1983.
3. Budach VGF: The role of radiation therapy in the management of gastric cancer. Ann Oncol 5(Suppl 3):37-48, 1994.
4. Gunderson LL: Gastric cancer. In Perez CA, Brady LW (eds): Principles and Practice of Radiation Oncology. Philadelphia: J.B. Lippincott Co., p 973, 1987.
5. Bakowski MT: ICRF 159; 1,2-di(3,5-dioxopiperazinyl)-propane; NSC 129943; razoxane. Cancer Treat Rev 3:95-107, 1976.
6. Hellmann K, Murkin GE: Synergism of ICRF 159 and radiotherapy in experimental tumors. Cancer 34:1033-1039, 1974.
7. Kimler BF: Interaction of razoxane and radiation on cultured Chinese hamster cells. Int J Radiat Oncol Biol Phys 8:1333-1338, 1982.
8. Norpoth K, Schaphaus A, Ziegler H, Witting U: Combined treatment of the Walker tumor with radiotherapy and ICRF 159. Z Krebsforsch 82:328, 1974.
9. Peters LJ: Modification of the radiocurability of a syngeneic murine squamous carcinoma by its site of growth, by electron-affinic drugs, and by ICRF 159. Br J Radiol 49:708-715, 1976.
10. Hellmann K, Rhomberg W: Radiotherapeutic enhancement by razoxane. Cancer Treat Rev 18:225-240, 1992.
11. Rhomberg WU: Radiotherapy combined with ICRF159. Int J Radiat Oncol Biol Phys 4:121-126, 1978.
12. Rhomberg W, Eiter H, Hergan K, Schneider B: Inoperable recurrent rectal cancer: Results of a prospective trial with radiation therapy and razoxane. Int J Radiat Oncol Biol Phys 30:419-425, 1994.
13. Ryall RDH, Hanham IWF, Newton KA, Hellmann K, Brinkley DM, Hjertaas OK: Combined treatment of soft tissue and osteosarcomas by radiation and ICRF 159. Cancer 34:1040-1045, 1974.
14. Bellet RE, Rozencweig M, von Hoff DD, Penta JS, Wasserman TH, Muggia FM: ICRF 159: Current status and clinical prospects. Eur J Cancer 13:1293-1298, 1977.
15. Creighton AM, Hellmann K, Whitecross S: Antitumor activity in a series of bis-diketopiperazines. Nature 222:384, 1969.
16. Sharpe HBA, Field EO, Hellmann K: The mode of action of the cytostatic agent ICRF 159. Nature 226:534-536, 1970.
17. Hellmann K, James SE, Salsbury AJ: Analysis of the antimetastatic action of the antimitotic agent ICRF 159. Br J Cancer 30:179, 1974.
18. Le Serve AW, Hellmann K: Metastases and the normalization of tumor blood vessels by ICRF 159. A new type of drug action. Br Med J 1:597-601; 1972.
19. Salsbury AJ, Burrage K, Hellmann K: Histological analysis of the antimetastatic effect of 1,2-bis(3,5-dioxopiperazinyl)propane. Cancer Res 34:843-849, 1974.
20. Abe M, Takahashi M: Intraoperative radiotherapy: The Japanese experience. Int J Radiat Oncol Biol Phys 5:863-868, 1981.
21. Asakawa H, Takeda T: High energy X-ray therapy of gastric carcinoma. J Jpn Soc Cancer Ther 8:362, 1973.
22. Kim GE, Shin HS, Seong JS, Loh JK, Suh CO, Lee JT, Roh JK, et al.: The role of radiation treatment in management of extrahepatic biliary tract metastasis from gastric carcinoma. Int J Radiat Oncol Biol Phys 28:711-717, 1994.
23. Tsukiyama I, Akine Y, Kajiura Y, Ogino T, Yamashita M, Egawa S, Hijikata J, Kitagawa T: Radiation therapy for advanced gastric cancer. Int J Radiat Oncol Biol Phys 15:123-127, 1988.
24. Shibuya S, Takase Y, Aoyagi H, et al.: Definitive proton beam radiation therapy for inoperable gastric cancer: A report of two cases. Radiat Med 9:35-40, 1991.
25. Falkson G, Falkson HC: Fluorouracil and radiotherapy of locally unresectable gastrointestinal cancer. Lancet 2:1252-1253, 1969.
26. Gastrointestinal Tumor Study Group: A comparison of combination chemotherapy and combined modality therapy for locally advanced gastric carcinoma. Cancer 49:1771-1777, 1982.
27. Moertel CG, Childs DS Jr, Reitemeier RJ, Colby MY, Holbook MA: Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 2:865-867, 1969.
28. O'Connell MJ, Gunderson LL, Moertel CG, et al.: A pilot study to determine clinical tolerability of intensive combined modality therapy for locally unresectable gastric cancer. Int J Radiat Oncol Biol Phys 11:1827, 1985.
29. Gunderson LL, Martin KJ, O'Connell MJ, Beart RW, Kvols LK, Nagorney DM: Residual, recurrent or unresectable gastrointestinal cancer. Role of radiation in single or combined modality treatment. Cancer 55:2250-2258, 1985.
30. Hallissey MT, Dunn JA, Ward LC, Allum WH, for the British Stomach Cancer Group: The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer. Lancet 343:1309-1312, 1994.
31. Hemans J, Bonenkamp JJ, Boon MC: Adjuvant therapy after curative resection for gastric cancer. J Clin Oncol 11:1441-1447, 1993.
32. Queisser W, Heim ME: Combined modality of radiation and chemotherapy for the treatment of gastric carcinoma. A review. Onkologie 12:156-160, 1989.
33. McVie JG, Soukop M, Calman KC, Stuart JFB, Trotter J: Failure of razoxane (ICRF 159) in gastric carcinoma. Abstr No 128. 5th Annual Meeting of the Medical Oncology Society, Nice, December 1-3, 1979.
34. Gunderson LL, Sosin H: Adenocarcinoma of the stomach: Areas of failure in a reoperation series (second or symptomatic looks). Clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 8:1-11, 1982.
35. Timothy A: Gastric cancer - Prospects for radiotherapy. International Congress on Diagnosis and Treatment of Upper GI Tumors, Mainz, September 9-11, 1980.